Diabetes Mellitus, Admission Glucose, and Outcomes After Stroke Thrombolysis: A Registry and Systematic Review [Clinical Sciences]
Conclusions—
These results confirm that AGL and history of diabetes mellitus are associated with poor clinical outcome after thrombolysis. AGL may be a surrogate marker of brain infarction severity rather than a causal factor. However, randomized controlled evidences are needed to address the significance of a tight glucose control during thrombolysis on clinical outcome.
Source: Stroke - Category: Neurology Authors: Desilles, J.-P., Meseguer, E., Labreuche, J., Lapergue, B., Sirimarco, G., Gonzalez-Valcarcel, J., Lavallee, P., Cabrejo, L., Guidoux, C., Klein, I., Amarenco, P., Mazighi, M. Tags: Acute Stroke Syndromes, Thrombolysis Clinical Sciences Source Type: research
More News: Brain | Diabetes | Diabetes Mellitus | Endocrinology | Hemorrhagic Stroke | Neurology | Stroke | Study